Related Experiment Video
Updated: Apr 3, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.4K
Biomarker-based trials in neuro-oncology
1Division of Biostatistics and Epidemiology, Weill Cornell Medical College, 402 East 67th Street, New York, NY 10065, USA. kvballman@gmail.com.
Chinese Clinical Oncology
|September 27, 2015
Summary
Biomarkers are crucial for tailoring brain tumor treatments and designing clinical trials. They help group tumors by genetic features and predict patient response, improving treatment selection and trial efficiency.
Area of Science:
- Neuro-oncology
- Genomics
- Clinical Trial Design
Background:
- Biomarker utilization is transforming brain tumor treatment strategies.
- Understanding tumor genetic/genomic profiles is key for personalized medicine.
Observation:
- Traditional clinical trials struggle with patient subsets due to heterogeneity.
- Novel trial designs are emerging to address tumor variability.
Findings:
- Biomarkers enable precise grouping of brain tumors based on molecular characteristics.
- Predictive biomarkers guide the selection of the most effective therapies for individual patients.
Implications:
- Biomarker-driven approaches enhance the efficiency of brain tumor clinical trials.
- Future trials will increasingly leverage biomarkers for targeted therapies and improved patient outcomes.
